SGO 2025 | SGO

Getty Images 2188501555

Save the date for SGO 2027 Annual Meeting on Women's Cancer

See you in Phoenix!

SGO 2026 Awards

See the Award Winners

Sgo26 Awards Researchand Donors

2026 Research Awards and Donor Appreciation

See the Award Winners

Matthew A. Powell, MD

Meet SGO Incoming President, Matthew A. Powell, MD

Emese Zsiros, MD, PhD, FACOG

Pembrolizumab Improves Survival in Platinum-Resistant Ovarian Cancer

Matthew A. Powell, MD

Hope on the Horizon

Phase 3 RUBY trial demonstrated positive outcomes for patients with primary advanced or recurrent endometrial cancer.

Sgo April 11th Selects 24

A Perfect Place to Lounge and Lean in

The Exhibit Hall’s Fellows’ Lounge provides young members with a comfortable place to network, organize, and recharge.

Step into new possibilities

Step into new possibilities

Learn about a targeted treatment that could make a difference for your patients.

SISTER: All for one and one for all?

Group peer support alone does not improve treatment completion for Black women with high‑risk endometrial cancer, but a one-on-one human connection did.

Sgo26 Awards

SGO 2026 Awards

High-caliber individuals are recognized for their work in research and service.

Sgo26 Awards Researchand Donors

2026 Research Awards and Donor Appreciation

Karen Lu, MD

Get to Know SGO’s Incoming President

Karen Lu, MD, brings a strong background and passion for building the gynecologic oncology community.

audience shot

A Potential New Detection Tool for Invasive Cervical Cancer

Circulating human papilloma virus DNA shows promise as a universal biomarker.

Ginger Gardner, MD, FACOG

Empowering Progress: The Foundation for Women's Cancer

The 2025 FWC strategic plan sets the course to improve outcomes for all patients.

A Potential Second-Line Treatment for Cervical Cancer

Combining BVAC-C and durvalumab in recurrent or metastatic cervical cancer.

Tamar Gootzen, MD

An Alternative Approach to Preventing Ovarian Cancer?

The ongoing TUBA-WISP II study could point the way to a new preventive approach for those at high risk for tubo-ovarian cancer.

Fang Jiang, MD, PhD

Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia

Angela Nolin, MD

It’s Time to Change the Diagnosis Protocol for Endometrial Cancer

Matthew A. Powell, MD

Tricky But Treatable

Kathleen N. Moore, MD

Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment

Linda Duska, MD, MPH

Pembrolizumab Plus Chemotherapy Regimen Yields Clinically Positive Outcomes for Treatment of Locally Advanced Cervical Cancer

Welcome video

Watch: Welcome to Seattle

headshots of the program chairs

Masterclasses and Hands-On Learning Set the Pace for SGO 2025

Amanda Nickles Fader, MD

Q&A With SGO President Amanda Nickles Fader, MD

convention attendee using an iPad

Get the SGO 2025 Mobile App

Fund the Future. Honor a Legacy

Invited Speaker: Gretchen Schwarze